Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Published on 09/01/202609/01/2026 by Research Hypothesis

Dr. Tong Qiao | Medicine and Health Sciences | Research Excellence Award

Dr. Tong Qiao | Medicine and Health Sciences | Head of ophthalmology at Shanghai Jiao Tong University | China

Dr. Tong Qiao is a distinguished clinician-scientist in pediatric ophthalmology with extensive expertise in the diagnosis and management of complex childhood eye disorders. She completed her foundational medical training with a Bachelor of Medicine, followed by a Master of Medicine, and later earned a Doctor of Philosophy in medicine from leading academic institutions in China, establishing a strong academic and clinical foundation in ophthalmology. Dr. Tong Qiao has authored 35 scholarly documents, received 343 citations, and maintains a 9 h-index, reflecting consistent academic influence and international research visibility in indexed scientific literature. Her publication record includes contributions to reputable, peer-reviewed journals, supporting evidence-based advancements in pediatric ophthalmology and visual sciences.

Citation Metrics (Scopus)

500

400

300

200

100

Citations
343

Documents
35

h-index
9

🟦 Citations 🟥 Documents 🟩 h-index

View Scopus Profile

Featured Publications

Digital measurement of pupil size, corneal size, and eccentricity in Guinea pigs using Python compared with traditional OCT
– Scientific Reports, Open Access

Bilateral superior oblique suture extension in pediatric A-pattern esotropia
– Medical Hypothesis Discovery and Innovation in Ophthalmology, Open Access

Surgical treatment and levator muscle protein analysis of congenital ptosis in craniosynostosis: A case-control study
– Medicine, Open Access

Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Published on 23/12/202523/12/2025 by Research Hypothesis

Dr. Laurie Margolies | Medicine and Health Sciences | Excellence in Research Award

Dr. Laurie Margolies | Medicine and Health Sciences | MD at Icahn School of Medicine at Mount Sinai | United States

Dr. Laurie Margolies is a distinguished academic physician and internationally recognized expert in breast imaging and diagnostic radiology, known for her leadership in integrating advanced imaging technologies and artificial intelligence into clinical cancer care. She received her undergraduate education at Brown University with an academic focus on biomedical ethics, followed by her medical degree from Yale University School of Medicine, where she developed a strong foundation in clinical medicine and research ethics. Dr. Laurie Margolies completed rigorous postgraduate training in internal medicine, diagnostic radiology, and advanced cross-sectional imaging, equipping her with comprehensive expertise across mammography, ultrasound, MRI, and tomosynthesis. Professionally, Dr. Laurie Margolies has held progressive academic appointments culminating in a full professorship in diagnostic, molecular, and interventional radiology at a leading academic medical center, while simultaneously serving in senior health-system leadership roles including Vice Chair and System Chief for Breast Imaging.

Citation Metrics (Scopus)

2500

2000

1500

1000

500

Citations2177

i10index92

h-index19

🟦 Citations 🟥 Documents 🟩 h-index

View Scopus Profile

Featured Publications

Performance of an Artificial Intelligence Support System on Screening Mammography Cases Proceeding to Stereotactic Biopsy
– Cancers (Open Access)

The Tyrer-Cuzick Risk Model: Is It Effective for All Races?
– Clinical Imaging

Patient Perception of Artificial Intelligence in Breast Imaging: A Pilot Survey Study
– Clinical Imaging

Suspicion for Sarcoma: Clinical Presentation, Multi-Modality Imaging Evaluation, and Ultrasound Artificial Intelligence-Based Decision Support
– Cancers (Open Access)

Breast Lymphoma: Imaging Features, Clinical Presentation, and Ultrasound Artificial Intelligence Decision Support
– Clinical Imaging

Artificial Intelligence for Assessment of Digital Mammography Positioning Reveals Persistent Challenges
– Journal of Breast Imaging

Breast Arterial Calcifications on Mammography: A Review of the Literature
– Review Article

Identifying Frequently Endorsed Benefits and Barriers to Breast Cancer Screening for African-Born Women in the NYC Metropolitan Area: A Pilot Study
– Journal of Racial and Ethnic Health Disparities

Low-Dose Chest CT: Participating in the Rise of Breast Density Awareness
– Journal of Women’s Health

Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Published on 04/10/202504/10/2025 by Research Hypothesis

Ms. Mengting Zhang | Medicine and Health Sciences | Best Researcher Award

Miss | Guangdong Medical University | Hong Kong

Ms. Mengting Zhang is a highly motivated and emerging scholar in the field of Medicine and Health Sciences, currently affiliated with Guangdong Medical University, Hong Kong, where she has established herself as a promising researcher contributing significantly to global advancements in medical and clinical research. With a strong academic foundation supported by a Doctoral degree in Medicine, Ms. Zhang has cultivated a comprehensive understanding of medical sciences, pharmacology, and translational research methodologies. Her educational journey reflects a deep commitment to precision, innovation, and interdisciplinary collaboration, equipping her with the skills to integrate clinical data, biomedical insights, and analytical modeling for impactful healthcare outcomes. Throughout her professional career, Ms. Zhang has demonstrated excellence in multiple research domains, including pharmacovigilance, clinical pharmacology, oral oncology, and biomedical informatics. She has been extensively involved in projects focusing on adverse drug event detection, molecular disease pathways, and bioinformatics-based health analysis, which are central to improving patient safety and therapeutic efficacy. Her academic record is reinforced by substantial contributions to peer-reviewed journals indexed in Scopus, Crossref, and Web of Science. Ms. Zhang has authored 11 documents, received 33 citations, and holds an h-index of 4, underscoring her consistent academic influence and growing recognition in the research community. She has published her findings in reputed international journals such as Oral Oncology, Expert Opinion on Drug Safety, Clinical Anatomy, and Journal of Diabetes Investigation, where her work has been well-cited and acknowledged for its scientific rigor and relevance. Her research explores complex relationships between genetics, drug response, and oral health conditions, with a focus on integrating real-world pharmacovigilance data and molecular evidence to enhance the accuracy of clinical outcomes. Ms. Zhang’s research skills encompass advanced data analysis, systematic review techniques, visual scientometrics using CiteSpace and VOSviewer, clinical trial evaluation, and statistical modeling. Professionally, she has collaborated with national and international researchers, contributing to studies utilizing FDA adverse event reporting systems and developing visual bibliometric maps that identify emerging medical trends. Her dedication to accuracy, methodological clarity, and ethical research practices has earned her recognition as a dependable contributor to academic development. Beyond research, Ms. Zhang is engaged in mentoring, peer-reviewing, and participating in collaborative scientific platforms that promote interdisciplinary learning and global knowledge sharing. Her commitment to innovation and collaboration highlights her as a future leader in the scientific community, capable of influencing both clinical and policy-level improvements in healthcare. Ms. Zhang’s achievements have positioned her as a potential candidate for several international honors and awards in biomedical sciences, including recognitions for research excellence and contribution to pharmacological safety evaluation. In conclusion, Ms. Mengting Zhang embodies academic integrity, scientific precision, and a vision for global medical progress.

Profile: ORCID | Scopus

Featured Publications

Zhang, M. (2025). Comment on “Uncovering chromatin factor landscapes in head and neck squamous cell carcinoma.” Oral Oncology. Citations: 7.
Zhang, M. (2025). Comment on “Tooth Anomalies in Patients With Nonsyndromic Orofacial Cleft: A Systematic Review and Meta‐Analysis.” Oral Diseases. Citations: 5.
Zhang, M. (2025). A real-world disproportionality analysis of the FDA adverse event reporting system events for ibuprofen. Expert Opinion on Drug Safety. Citations: 8.
Zhang, M. (2024). A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data. Journal of Diabetes Investigation. Citations: 6.
Zhang, M. (2024). Research advances and trends in anatomy from 2013 to 2023: A visual analysis based on CiteSpace and VOSviewer. Clinical Anatomy. Citations: 7.

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Published on 07/05/202507/05/2025 by Research Hypothesis

ALI KAISSI | Medicine and Health Sciences | Excellence in Research Award

Prof. Dr ALI KAISSI, orthopaedic Hospital Speising Vienna, Austria

Dr. Ali Al Kaissi is a distinguished medical scientist and consultant in pediatric orthopedics with an illustrious international career spanning over four decades. A graduate of Al-Azhar University, Cairo, he pursued postgraduate training and specialization in the United Kingdom, Tunisia, Austria, and Russia. He is best known for his groundbreaking contributions to pediatric skeletal dysplasias and genetic disorders, including the identification of Al Kaissi syndrome (OMIM 617694). As an honorary professor and senior researcher, he has collaborated with prestigious institutions such as the Turner Orthopedic Institute (Russia), Ilizarov Institute (Kurgan), and the University of Saskatchewan (Canada). Dr. Al Kaissi’s multidisciplinary expertise and diagnostic acumen have contributed to the understanding of complex orthopedic and craniofacial disorders. His global impact is reflected through his numerous publications, awards, and honorary appointments.

Publication Profile

Scopus

Education

Dr. Al Kaissi received his foundational medical degree from Al-Azhar University, Cairo (1978). He continued his postgraduate education in the United Kingdom, earning a Certificate in Pediatrics (1988), followed by a Master’s degree in Pediatric Developmental Abnormalities from the University of Warwick (1990). His academic excellence was later recognized with a Doctor of Science (Honorary) from the Turner Scientific Research Institute for Children’s Orthopedics in Saint Petersburg, Russia (2017). His educational path reveals a strong emphasis on pediatric orthopedics, developmental abnormalities, and rare syndromic disorders. His continuous pursuit of medical education, coupled with his pioneering research, has laid the foundation for significant clinical contributions and novel diagnostic insights into congenital and acquired musculoskeletal diseases.

Experience

Dr. Al Kaissi has held numerous high-level clinical and research positions internationally. Since 2005, he has served as a consultant and scientist at the Orthopedic Hospital of Speising in Vienna, Austria. Previously, he led pediatric orthopedic clinical research at the Children’s Hospital in Tunis, Tunisia (1993–2005), where he also established a national center for early recognition of congenital malformation complexes. He has been involved in key medical posts in Iraq, the UK, and Russia, spanning from senior house officer roles to visiting professorships. His experience encompasses both the clinical management of pediatric orthopedic conditions and pioneering research into rare skeletal dysplasias and syndromes. His extensive global collaborations and ability to identify novel pathologies have positioned him as a leader in diagnostic orthopedic research.

Awards and Honors

Dr. Al Kaissi has been the recipient of numerous international awards recognizing his excellence in clinical research and diagnostics. He received the prestigious Russian Golden Medal for Distinguished Clinicians and the Silver Dagestani Sword in 2019. In 2017, he was conferred an Honorary Doctorate (DSc) from the Turner Pediatric Orthopedic Institute, Russia. His contributions have been acknowledged by ministries of health in Russia and Tunisia, among others. He holds honorary professorships at premier Russian institutions including the Ilizarov Institute and the Pediatric Kidney Clinic of Dagestan. His honors reflect not only individual achievement but also the broader impact of his diagnostic innovations on pediatric care and genetic research.

Research Focus

Dr. Al Kaissi’s research focuses on pediatric skeletal dysplasias, craniofacial anomalies, syndromic disorders, and orthopedic genetics. He has discovered and characterized several new syndromes including “Al Kaissi syndrome” (OMIM 617694) and contributed to the understanding of 3MC syndrome and Desbuquois dysplasia-like conditions. His diagnostic insights into wormian bones and thoracic collapse disorders have redefined clinical approaches in developmental orthopedics. His collaboration with environmental scientists has broadened his scope to ecotoxicology and skeletal pathology in wildlife exposed to toxins, reflecting a unique intersection between human and environmental health. His publications cover radiographic and tomographic evaluations, syndrome delineation, and the interplay of environmental exposures with skeletal disease. His work continues to shape diagnostic criteria and management protocols globally.

Publication Top Notes

Al Kaissi Syndrome – OMIM (617694): Identified a novel syndrome with growth retardation, spinal malformation, and dysmorphic facies.
3MC Syndrome with Baraitser – OMIM (257920): Defined craniofacial and skeletal anomalies in conjunction with Michael Baraitser.
“Progressive Collapse of the Thoracic Cage” – American Journal of Medicine, 2017.
“Novel Conception of Wormian Bones” – Diagnostics Journal, 2023.
“Skeletal Pathology in Arctic Wildlife” – Science of the Total Environment, 2019 & Ecotoxicology and Environmental Safety, 2020.
“Meticulous and Early Understanding of Cranial Defects Can Save Lives” – Children, 2023.
“Craniofacial Malformations in Syndromic Entities” – Diagnostics, 2022.
“Arthrogryposis and Escobar Syndrome” – Minerva Pediatrics, 2024.
“Non-lethal ZMPSTE24 Mutation in Progeria” – Clinical Genetics, 2023.

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Published on 12/03/202512/03/2025 by Research Hypothesis

Lucia Ciranna | Medicine and Health Sciences | Women Researcher Award

Assoc. Prof. Dr Lucia Ciranna, Università di Catania, Italy

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her groundbreaking research on the serotonin brain system, Fragile X Syndrome, and neurodevelopmental disorders. With a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg (1995) and a Pharmacy degree from the University of Catania (1989), she has significantly advanced understanding of neurological diseases. As an Associate Professor of Physiology at the University of Catania since 2006, she has led innovative studies on neurodevelopment and therapeutic interventions. Her extensive research contributions, spanning over three decades, have earned her prestigious qualifications in France and Italy. Dr. Ciranna’s work has been instrumental in exploring the therapeutic potential of serotonin modulation, glial interactions, and receptor mechanisms in neurological disorders. Her prolific publication record and dedication to advancing neuroscience make her a deserving recipient of the Women Researcher Award. 🧠📚🏅

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist with a Ph.D. in Neuroscience from Louis Pasteur University of Strasbourg, France (1995) 🧠, where she focused on serotonin neurotransmission and neurodevelopment. She earned her Pharmacy degree from the University of Catania (1989) 💊, specializing in neuropharmacology and brain physiology. Her postdoctoral research at the University of Catania (1995-1998) 🔬 explored serotonin’s role in synaptic plasticity and cognition. Further advancing her expertise, she trained in molecular neuroscience and pharmacology (1998-2000) 🎓. Dedicated to lifelong learning, she actively engages in international neuroscience workshops and research collaborations 📖.

Experience

Assoc. Prof. Dr. Lucia Ciranna is a distinguished physiologist at the University of Catania (2006-Present) 🏫, leading groundbreaking research on serotonin’s role in neurological disorders and innovative therapeutic strategies. Previously, she was a researcher at the same institution (1994-2006) 🔬, investigating neurophysiology in cognitive impairments and receptor signaling. She earned her Ph.D. from Louis Pasteur University of Strasbourg (1990-1994) 🎓, focusing on neurodevelopmental mechanisms and serotonin modulation in brain function. Earlier, she contributed to neuropharmacology research at the University of Catania (1989-1990) 🧬. As a scientific collaborator with international neuroscience labs 🌍, she continues exploring cutting-edge advancements in the field.

Awards and Honors

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist recognized for her contributions to neurophysiology 🧠. She achieved the Qualification to the function of Professeur des Université in France (2012) 🇫🇷 and later became a Professore Ordinario (Full Professor of Physiology) in 2018 🎓. Her research has been supported by prestigious international neuroscience grants 💰, driving innovation in the field. A sought-after speaker, she has delivered distinguished lectures at major neurophysiology conferences worldwide 🎤. Dr. Ciranna’s groundbreaking work on Fragile X Syndrome has earned her accolades for excellence in neurodevelopmental research 🏅.

Presentation

Assoc. Prof. Dr. Lucia Ciranna is a distinguished neuroscientist specializing in serotonin receptor modulation and its implications for neurodevelopmental disorders 🧠🔬. She has delivered numerous invited seminars and conference presentations worldwide, focusing on the role of 5-HT7 serotonin receptors in synaptic plasticity, cognition, and behavior. Her research explores therapeutic strategies for Fragile X Syndrome and Autism Spectrum Disorders, with key contributions to understanding serotonin-mediated neuromodulation 🎓🧪. Dr. Ciranna has also engaged in public science communication, appearing on RAI Telethon broadcasts 📺. Her work continues to shape novel approaches for treating cognitive disorders through serotonin receptor activation. 🌍📚

Research Focus

Assoc. Prof. Dr. Lucia Ciranna is dedicated to unraveling the complexities of the serotonin brain system 🧠, exploring its role in neurological disorders and potential therapeutic interventions. Her research focuses on Fragile X Syndrome 🧬, aiming to develop targeted treatments for cognitive deficits. She investigates neurodevelopmental disorders 💡, shedding light on autism, intellectual disabilities, and brain dysfunctions. Her work also delves into glial-neuronal interactions 🤝, examining their impact on neurodevelopment and inflammation. Passionate about therapeutic innovations in neuroscience 🏥, she seeks novel drug targets and treatment strategies to improve neurological health and patient outcomes.

Publication Top Notes

Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells

Editorial: Role of glia in neurodevelopmental disorders

Increased Heat Pain Tolerance but Hyperalgesia to Tonic Inflammatory Pain in the CRND8 Mouse Model of Alzheimer’s Disease

Purinergic ionotropic P2X7 and metabotropic glutamate mGlu₅ receptors crosstalk influences pro-inflammatory conditions in microglia

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Published on 24/12/202424/12/2024 by Research Hypothesis

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Anne Vertigan, John Hunter Hospital, Australia

Assoc. Prof. Dr. Anne Vertigan is an experienced Speech Pathologist with a career spanning over 30 years. She holds multiple degrees, including a PhD in chronic cough and airway hyperresponsiveness. Dr. Vertigan is the Director of Speech Pathology at Greater Newcastle Acute Hospital and has extensive experience in leadership and clinical roles. She has contributed significantly to research, focusing on chronic cough, laryngeal dysfunction, and asthma. Dr. Vertigan has been invited to speak at numerous international conferences and has received several prestigious grants. She is also an Associate Editor for the European Respiratory Journal. 📚🎤💬👩‍⚕️🌏

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Anne Vertigan holds a B.App.Sc. (Speech Pathology) from La Trobe University (1991), an MBA from the University of Newcastle (2008), and a PhD from the University of Queensland, where she researched chronic cough and extrathoracic airway hyperresponsiveness syndrome, awarded in 2007. She also earned a Master in Clinical Epidemiology (2023) and a Master in Medical Statistics (2023) from the University of Newcastle. Dr. Vertigan’s academic and professional journey reflects her commitment to advancing knowledge in health, particularly in respiratory conditions and clinical research. 📚🎓💡🩺

Experience

Assoc. Prof. Dr. Anne Vertigan is a seasoned speech pathologist with an extensive career in healthcare leadership. She has served as the Director of Speech Pathology at the Greater Newcastle Acute Hospital Network since 2000. Previously, Dr. Vertigan was a Post-Doctoral Research Fellow at the NHMRC Centre for Clinical Excellence in Respiratory & Sleep Medicine (2008-2009). Her roles include District Profession Director of Speech Pathology at Hunter New England Health (2008-2015) and Director at John Hunter Hospital (1994-2000). With additional experience in various hospitals and community health centers, Dr. Vertigan has made significant contributions to speech pathology and healthcare. 🏥👩‍⚕️📚

Presentations

Assoc. Prof. Dr. Anne Vertigan is a renowned expert in laryngeal dysfunction, chronic cough, and voice disorders, delivering numerous invited talks at prestigious international conferences. In June 2024, she spoke at the Inducible Laryngeal Obstruction Conference in Pittsburgh, USA, on topics such as the hypersensitive larynx, laryngeal dysfunction, and the relationship between inducible laryngeal obstruction (ILO) and severe asthma. She also addressed dysphagia management and laryngeal hyperresponsiveness at the Phonosurgery Association of India in February 2024. Additionally, Dr. Vertigan shared her expertise at the French Society of ENT Congress and the ENT Head & Neck Instructional Course in Singapore. 🌍🎤👩‍⚕️

Grants

Assoc. Prof. Dr. Anne Vertigan has been awarded several prestigious grants and recognitions for her research in respiratory health. These include the $10,000 Ignite EMCR Equipment Grant (2018) for BioRadio Respiratory Inductive Plethysmography, and the $5,000 Strategic Research Pilot Grant (2020) to understand breathlessness in asthma. She also contributed to the $320,490.62 Medical Research Futures Fund on bushfire impact (2020), and the NHMRC’s $2.5 million CREATT Centre for asthma research (2020). In 2021, her work on non-pharmacological treatments for interstitial lung diseases won the SPP Robalo Cordeiro Award. Her latest project focuses on minimizing corticosteroid use in asthma. 🫁💡🌿

Research Focus

Assoc. Prof. Dr. Anne Vertigan’s research primarily focuses on respiratory diseases, particularly chronic cough, breathlessness, and asthma. She investigates the psychophysiological correlates of breathlessness and the impact of exposure to environmental factors like wildfire smoke. Dr. Vertigan also explores respiratory issues related to vocal cord dysfunction and laryngeal hypersensitivity. She is involved in studies aimed at improving diagnostic and therapeutic approaches for conditions such as chronic cough in children and adults. Her work aims to enhance understanding and management of airway conditions in clinical settings. 🌬️🫁👩‍⚕️🔬🌱

Publication top Notes

Abnormal breathing pattern features in chronic refractory cough

Understanding Breathlessness Burden and Psychophysiological Correlates in Asthma

Respiratory Diseases Associated With Wildfire Exposure in Outdoor Workers

Misconceptions on behavioral cough suppression therapy for pediatric nonspecific cough: A response to Weinberger and Buettner’s commentary on Fujiki et al.

Living With Asthma and Vocal Cord Dysfunction/Inducible Laryngeal Obstruction: “I Just Can’t Get Air In”

Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Published on 05/08/202405/08/2024 by Research Hypothesis

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Dr Antoinette Oot, NYU / NYC HHC Bellevue, United States

Based on the information provided, Antoinette Oot, MD, MPH, appears to be a strong candidate for a Best Researcher Award.

Publication profile

Scopus

Education

Antoinette Oot, MD, MPH, has a robust educational background that spans several prestigious institutions. She is currently a Fellow in Complex Family Planning at New York University/NYC Health + Hospitals Bellevue, a role she has held since July 2024. Previously, she served as the Administrative Chief Resident in the Department of Obstetrics and Gynecology at the same institution from 2020 to 2024. Dr. Oot earned her M.D./M.P.H. with honors from Northwestern University, Feinberg School of Medicine in 2020, and holds a B.Sc. in Chemistry with Honors from Brown University. Her early academic journey began at New York University, where she studied biochemistry. This educational trajectory demonstrates her commitment to both clinical excellence and public health, making her a strong candidate for the Best Researcher Award.

Work Experience & Post-Graduate Learning

Dr. Oot has accumulated significant work experience and engaged in continuous post-graduate learning, particularly in leadership and educational roles. As the Administrative Chief Resident at NYU, she optimized personnel coverage, facilitated communication, and promoted a fair work environment. She also served as the Resident OB/Gyn Clerkship Advisor, providing mentorship and improving medical education. Additionally, Dr. Oot has been an advocate for resident perspectives as a Class Representative on the Education Committee at NYU Langone Hospitals. Her experience extends to mentoring students and contributing to curricular development at Northwestern University. These roles highlight her dedication to improving medical education and her leadership skills, reinforcing her suitability for the Best Researcher Award.

Honors/Awards

Dr. Oot has received numerous honors and awards throughout her career, reflecting her outstanding contributions to the field of obstetrics and gynecology as well as public health. Notable awards include the 2023 Ryan Program Resident Award for Excellence in Family Planning and the 2022 Resident Recognition Award for Medical Student Education from NYU OB/GYN. She also received the Excellence in Public Health Award from the US Public Health Services in 2020 and was elected to the Gold Humanism Honor Society in 2019. These accolades underscore her exceptional research, clinical skills, and commitment to advancing women’s health, making her an exemplary candidate for the Best Researcher Award.

Presentations

Dr. Oot has actively participated in academic presentations, sharing her research findings at national conferences. In 2023, she delivered an oral presentation at the American Public Health Association Annual Meeting on increasing HIV pre-exposure prophylaxis among cisgender women. Her poster presentations at the Society of Gynecologic Surgeons and Society of Maternal-Fetal Medicine annual meetings further highlight her research involvement in women’s health and obstetric care. Her ability to present complex medical research to her peers indicates her leadership in the field and further supports her candidacy for the Best Researcher Award.

Publications

Dr. Oot has an impressive list of publications, contributing to various high-impact journals in the fields of obstetrics, gynecology, and public health. Her research spans a range of topics, including maternal morbidity, HIV prevention, and vaginal health, showcasing her broad expertise and commitment to improving patient outcomes. Notably, her recent work includes a mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention published in AIDS Care and studies on maternal health in the Journal of Women’s Health. Her extensive publication record is a testament to her research capabilities, making her a strong candidate for the Best Researcher Award.

Personal Interests

Outside of her professional life, Dr. Oot enjoys baking, needlepoint, embroidery, and attending comics and art festivals. These hobbies provide a well-rounded perspective to her character, balancing her rigorous academic and professional pursuits with creative and relaxing activities. This personal insight into Dr. Oot’s life adds to her overall profile, showing her as a dedicated and multifaceted individual, further strengthening her candidacy for the Best Researcher Award.

Conclusion

Dr. Antoinette Oot’s extensive education, leadership in medical education, significant research contributions, and numerous awards position her as an outstanding candidate for the Best Researcher Award. Her dedication to advancing women’s health and public health, coupled with her personal commitment to mentorship and education, make her a deserving recipient of this recognition.

Research focus

The research focus of this individual centers on women’s health, obstetrics, and gynecology, with a particular emphasis on conditions affecting women such as genitourinary syndrome of menopause, maternal morbidity, and bacterial vaginosis. They also explore healthcare practices and policies, including interventions for HIV prevention and the evaluation of healthcare delivery in obstetric settings. Additionally, they investigate the use of electronic health records for analyzing maternal and neonatal complications, reflecting a commitment to improving health outcomes for women through research and healthcare policy reform. 🌸👩‍⚕️📊💊

Publication top notes

A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause

A mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention for healthcare providers in a NYC safety-net hospital-based obstetrics and gynecology clinic